BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

  • Bruno Bockorny
  • , Valerya Semenisty
  • , Teresa Macarulla
  • , Erkut Borazanci
  • , Brian M. Wolpin
  • , Salomon M. Stemmer
  • , Talia Golan
  • , Ravit Geva
  • , Mitesh J. Borad
  • , Katrina S. Pedersen
  • , Joon Oh Park
  • , Robert A. Ramirez
  • , David G. Abad
  • , Jaime Feliu
  • , Andres Muñoz
  • , Mariano Ponz-Sarvise
  • , Amnon Peled
  • , Tzipora M. Lustig
  • , Osnat Bohana-Kashtan
  • , Stephen M. Shaw
    • Ella Sorani, Marya Chaney, Shaul Kadosh, Abi Vainstein Haras, Daniel D. Von Hoff, Manuel Hidalgo

Research output: Contribution to journal › Article › peer-review

443 Scopus citations

Fingerprint

Dive into the research topics of 'BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology